Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits

Anesthesiology

Volumn 101, Issue 5, 2004, Pages 1160-1166

  Chiari, Pascal C ^a   Pagel, Paul S ^b,c   Tanaka, Katsuya ^a   Krolikowski, John G ^a   Ludwig, Lynda M ^a   Trillo Jr , Raul A ^d   Puri, Navneet ^d   Kersten, Judy R ^a   Warltier, David C ^a,b,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Medical College of Wisconsin and Marquette University   (United States)

^d Baxter Healthcare Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENFLURANE; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; LIPID; PENTOBARBITAL; SEVOFLURANE; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; EMULSION; HALOGENATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESPIRATION DEPRESSION; SEDATION;

ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANIMALS; BLOOD GAS ANALYSIS; CHEMISTRY, PHARMACEUTICAL; EMULSIONS; ENFLURANE; EXCIPIENTS; HEMODYNAMIC PROCESSES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; MALE; METHYL ETHERS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RABBITS;

EID: 7244228004     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200411000-00016     Document Type: Article

References (29)

1. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC: Mechanisms of cardioprotection by volatile anesthetics. ANESTHESIOLOGY 2004; 100:707-21
2. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC: Anaesthetics and cardiac preconditioning: I. Signalling and cytoprotective mechanisms. Br J Anaesth 2003; 91:551-65
3. Zaugg M, Lucchinetti E, Garcia C, Pasch T, Spahn DR, Schaub MC: Anaesthetics and cardiac preconditioning: II. Clinical implications. Br J Anaesth 2003; 91:566-76
4. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, Pagel PS, Warltier DC: Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: Role of cyclooxygenase 2. ANESTHESIOLOGY 2004; 100:525-31
5. World Medical Association, American Physiological Society: Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 2002; 283:R281-3
6. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council: Guide for the Care and Use of Laboratory Animals, 7th edition. Washington, D.C., National Academy Press, 1996
7. Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF Jr, Kersten JR, Pagel PS, Warltier DC: Mechanism of preconditioning by isoflurane in rabbits: A direct role for reactive oxygen species. ANESTHESIOLOGY 2002; 97:1485-90
8. Gassmayr S, Stadnicka A, Suzuki A, Kwok WM, Bosnjak ZJ: Isoflurane sensitizes the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to pinacidil. ANESTHESIOLOGY 2003; 98:114-20
9. Warltier DC, Zyvoloski MG, Gross GJ, Hardman HF, Brooks HL: Determination of experimental myocardial infarct size. J Pharmacol Methods 1981; 6:199-210
10. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M: Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, multicenter study. ANESTHESIOLOGY 2003; 98:1315-27
11. Warltier DC, Pagel PS, Kersten JR: Approaches to the prevention of perioperative myocardial ischemia. ANESTHESIOLOGY 2000; 92:253-9
12. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC: Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. ANESTHESIOLOGY 1999; 91:1437-46
13. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC: Isoflurane mimics ischemic preconditioning via activation of KATp channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87: 361-70
14. Steward A, Allott PR, Cowles AL, Mapleson WW: Solubility coefficients for inhaled anaesthetics for water, oil and biological media. Br J Anaesth 1973; 45:282-93
15. Wallin RF, Regan BM, Napoli MD, Stern IJ: Sevoflurane: A new inhalational anesthetic agent. Anesth Analg 1975; 54:758-66
16. Drummond JC: MAC for halothane, enflurane, and isoflurane in the New Zealand white rabbit: and a test for the validity of MAC determinations. ANESTHESIOLOGY 1985; 62:336-8
17. Scheller MS, Saidman LJ, Partridge BL: MAC of sevoflurane in humans and the New Zealand white rabbit. Can J Anaesth 1988; 35:153-6
18. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Is isoflurane-induced preconditioning dose related? ANESTHESIOLOGY 2002; 96:675-80
19. ATP channels and opioid receptors. ANESTHESIOLOGY 2003; 98:705-11
20. Riess ML, Kevin LG, Camara AKS, Heisner JS, Stowe DF: Dual exposure to sevoflurane improves anesthetic preconditioning in intact hearts. ANESTHESIOLOGY 2004; 100:569-74
21. ATP channels via multiple signaling pathways. ANESTHESIOLOGY 2002; 97:4-14
22. Piriou V, Chiari P, Lhuillier F, Bastien O, Loufoua J, Raisky O, David JS, Ovize M, Lchot JJ: Pharmacological preconditioning: Comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium. Br J Anaesth 2002; 89:486-91
23. Banerjee S, Tang XL, Qiu Y, Takano H, Manchikalapudi S, Dawn B, Shirk G, Bolli R: Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. Am J Physiol Heart Circ Physiol 1999; 277:H2488-94
24. Dawn B, Takano H, Tang XL, Kodani E, Banerjee S, Rezazadeh A, Qiu Y, Bolli R: Role of Src protein tyrosine kinases in late preconditioning against myocardial infarction. Am J Physiol Heart Circ Physiol 2002; 283:H549-56
25. Fryer RM, Hsu AK, Gross GJ: ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol 2001; 96:136-42
26. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, Bolli R: Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 1998; 98:441-9
27. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, Bolli R: Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci U S A 2000; 97:10197-202
28. Kehl F, Pagel PS, Krolikowski JG, Gu W, Toller W, Warltier DC, Kersten JR: Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Anesth Analg 2002; 95:1162-8
29. Maxwell MP, Hearse DJ, Yellon DM: Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987; 21:737-46